contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


inhalation-sciences-secures-important-ip-rights

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

(Stockholm 29 October, 2020) Swedish medtech innovator Inhalation Sciences Sweden AB (publ), forerunner in the development of next-generation labtech equipment for inhalation research, secures...

(Stockholm 29 October, 2020) Swedish medtech innovator Inhalation Sciences Sweden AB (publ), forerunner in the development of next-generation labtech equipment for inhalation research, secures important IP rights for its state-of-the-art laboratory system PreciseInhale[®]. The unique system allows scientists to work with several different preclinical services based on PreciseInhale and measure how inhaled particles act in our lungs and affect our health.Inhalation Sciences Sweden AB reports the following IP-related events.Important patent secured in the US for PreciseInhale[®] Today's standard technologies for scientists, helping them measure how inhaled particles act in our lungs and affect our health, are imprecise and largely unchanged since the 1950's. PreciseInhale[®] sets a completely new standard as it delivers results with a proven high correlation between laboratory in vitro testing, and animal exposure, and soon also to human testing - enabling more cost-efficient medicines for a large variety of accelerating global killer diseases of the respiratory tract.Inhalation Sciences now reports that the US patent office has issued a notice on October 20, 2020, that a US Patent will be granted based on the application 14/906,701. The US Patent will cover the unique aerosol generating technology used in PreciseInhale. Patents to this key element of PreciseInhale have previously been granted in the major EU markets, such as the UK, France and Germany. Together with other patents, Inhalation Sciences has now increased the possibility of controlling future market expansion for the product PreciseInhale.CEO Manoush Masarrat: "This new patent is of vital strategic importance for us. Following our recently approved new patent for `regional targeting' (<a href="https://inhalation.se/investors/pressmeddelanden/?pressreleaseId=3706611">https://inhalation.se/investors/pressmeddelanden/?pressreleaseId=3706611</a>), it is yet further proof of how we continue to be the leading innovators in aerosol and inhalation R&amp;D, a fast-growing and ever more urgent market."Lucrative market opportunities The global respiratory care devices market is expected to grow from USD 21 billion in 2019 and to reach USD 40 billion by 2027*. The growth can mainly be attributed to the high prevalence of respiratory diseases, a rising aging population across the globe, high prevalence of smoking, constantly increasing pollution levels, increasing incidence of preterm births, and lifestyle changes. Also, a lack of awareness in respiratory care is leading to an underdiagnosed and undertreated population.*Fior Markets report 417943 on Medical Devices